CT
IMPV

Cambridge Trust’s Imperva, Inc. IMPV Stock Holding History

Cambridge Trust’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,638
Closed -$422K – 265
2017
Q4 		$422K Sell
10,638
-13,111
-55% -$546K 0.03% 195
2017
Q3 		$1.03M Sell
23,749
-90
-0.4% -$4.11K 0.07% 127
2017
Q2 		$1.14M Buy
23,839
+1,081
+5% +$50.4K 0.08% 123
2017
Q1 		$934K Buy
22,758
+5,923
+35% +$247K 0.06% 140
2016
Q4 		$646K Buy
16,835
+291
+2% +$11.8K 0.05% 157
2016
Q3 		$889K Buy
16,544
+1,370
+9% +$63.6K 0.07% 135
2016
Q2 		$653K Buy
+15,174
New +$637K 0.05% 148

Other funds holding IMPV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Cambridge Trust's IMPV Position: Q1 2018 in Review

Cambridge Trust sold out of Imperva, Inc. (IMPV) in Q1 2018, closing a stake of 10,638 shares — an estimated $422K sold.

Cambridge Trust first reported a position in IMPV in Q2 2016 and held it in 7 quarters. The position peaked at $1.14M in Q2 2017. 206 funds tracked by Wall St. Rank hold IMPV as of Q1 2018.

  • Cambridge Trust reported no remaining Imperva, Inc. position as of Q1 2018 after selling out during the quarter.
  • Cambridge Trust sold 10,638 Imperva, Inc. shares in Q1 2018, an estimated $422K.
  • Cambridge Trust first reported a position in Imperva, Inc. in Q2 2016 and held it in 7 quarters.
  • Cambridge Trust's Imperva, Inc. position peaked at $1.14M in Q2 2017.
  • 206 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2018.

Based on Cambridge Trust's 13F filing for Q1 2018, filed 27 Apr 2018.